Park Ha Biological Technology Co., Ltd. revenue

Park Ha Biological Technology Co., Ltd.'s revenue was $2.5m in fiscal 2025, up 6.0% on the year before. Since fiscal 2022 ($1.9m) it has grown at a compound 9.6% a year.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Park Ha Biological Technology Co., Ltd.: revenue history, annual
Fiscal year	2022Oct 2022	2023Oct 2023	2024Oct 2024	2025Oct 2025
Revenue	1,919	2,459	2,382	2,525
Growth on the year before	—	+28.1%	−3.1%	+6.0%
Gross profit	1,410	2,148	2,187	2,382
Gross margin	73.5%	87.4%	91.8%	94.4%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Specialty Chemicals: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Park Ha Biological Technology Co., Ltd.	$2.5m	6.0%	—
Senestech, Inc.	$2.4m	13.4%	29.8%
Zone Frontier Inc.	$3.4m	64.2%	—
Citrotech Inc.	$1.3m	-26.4%	134.1%
Research Frontiers Inc	$654,232	-46.5%	-2.9%
J-star Holding Co., Ltd.	$9.9m	-43.5%	—

Compare with peers

Head to head: BYAH vs SNES BYAH vs ZONE BYAH vs CITR BYAH vs REFR

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Park Ha Biological Technology Co., Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Park Ha Biological Technology Co., Ltd.